Reports for EFAVIRENZ
Ingredient
EFAVIRENZ
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-EFAVIRENZ-EMTRICITABINE-TENOFOVIR | 300MG 200MG 600MG | TABLET | Resolved | 2024-07-12 | 2024-09-06 | 232821 |
| APO-EFAVIRENZ-EMTRICITABINE-TENOFOVIR | 300MG 200MG 600MG | TABLET | Resolved | 2023-04-14 | 2023-07-07 | 189653 |
| AURO-EFAVIRENZ | 600MG | TABLET | Resolved | 2018-09-17 | 2018-10-10 | 61711 |
| AURO-EFAVIRENZ-EMTRICITABINE-TENOFOVIR | 300MG 200MG 600MG | TABLET | Resolved | 2024-10-25 | 2024-12-03 | 241174 |
| AURO-EFAVIRENZ-EMTRICITABINE-TENOFOVIR | 600MG 200MG 300MG | TABLET | Avoided shortage | 2020-12-07 | 2021-02-03 | 129766 |
| AURO-EFAVIRENZ-EMTRICITABINE-TENOFOVIR | 600MG 200MG 300MG | TABLET | Resolved | 2021-04-12 | 2021-06-03 | 137370 |
| AURO-EFAVIRENZ-EMTRICITABINE-TENOFOVIR | 300MG 200MG 600MG | TABLET | Resolved | 2023-09-15 | 2023-11-13 | 204524 |
| JAMP-EFAVIRENZ | 600MG | TABLET | Actual shortage | 2023-10-18 | 2024-12-03 | 207333 |
| JAMP-EFAVIRENZ | 600MG | TABLET | Resolved | 2022-04-06 | 2022-07-20 | 158082 |
| MYLAN-EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE | 600MG 200MG 300MG | TABLET | Avoided shortage | 2020-04-29 | 2020-07-09 | 113424 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ATRIPLA | 300MG 200MG 600MG | TABLET | Discontinued | 2021-08-17 | 2022-01-01 | 144260 |
| SUSTIVA 200MG | 200MG | CAPSULE | Discontinued | 2021-06-14 | 2023-04-01 | 140881 |
| SUSTIVA 50MG | 50MG | CAPSULE | Discontinued | 2021-06-14 | 2023-04-01 | 140884 |
| SUSTIVA TABLETS | 600MG | TABLET | Discontinued | 2021-06-14 | 2022-10-01 | 140887 |
| TEVA-EFAVIRENZ | 600MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256134 |
Showing 1 to 5 of 5